Lactobacillus acidophilus L-92
What does the research say about Lactobacillus acidophilus L-92?
14 health outcomes synthesisedLactobacillus acidophilus L-92 has been studied across 12 health outcomes, with the strongest evidence supporting its use for reducing atopic dermatitis severity and improving related symptoms. The most robust research includes 6 studies on reduced atopic dermatitis severity, all showing moderate beneficial effects, particularly in children and adults with clinically diagnosed atopic dermatitis. Doses were not consistently reported across studies, though one RCT used 20 mg L-92 per day, and the evidence is primarily from Japanese populations.
Strongest evidence: The most well-supported outcomes are for atopic dermatitis. For reduced atopic dermatitis severity, 6 of 6 studies (evidence strength: moderate) reported moderate beneficial effects, with 4 reaching statistical significance, in children and adults with clinically diagnosed atopic dermatitis. Similarly, improved atopic dermatitis symptoms showed large beneficial effects in 4 of 4 studies (2 RCTs), with statistically significant SCORAD improvements in Japanese adults (p=0.002) and children. A related outcome, improved atopic dermatitis severity, also showed moderate effects in 4 of 4 studies (3 significant), with the most studied dose being 20 mg L-92/day in one RCT.
Mixed or weaker evidence: Outcomes with low or very low evidence strength include improved immune function (12 studies, all beneficial but small effect, dominated by narrative reviews), reduced allergic symptoms (11 studies, all beneficial with moderate effect, but no primary RCTs), reduced severity of allergic rhinitis symptoms (10 studies, all beneficial but only 1 significant), and reduced inflammation (9 studies, all beneficial but small effect, only 1 of 9 significant). Improved gut microbiota balance has very low evidence (6 studies, all reviews, mixed effect sizes). Other outcomes like improved immune modulation, improved gut health, improved allergic symptoms, and increased antioxidant activity all have low evidence with no significant primary human trials.
Effective dose patterns: Only one outcome (improved atopic dermatitis severity) reported a specific dose: 20 mg L-92 per day in one RCT. No other outcomes had consistent dose data across studies, limiting the ability to identify a typical effective dose for other conditions.
Population insights: Research consistently focuses on populations with atopic dermatitis—particularly Japanese children and adults. Some studies extend to adults with atopic dermatitis and food allergy, young children (aged 1 month to 10 years), and allergic rhinitis patients. Populations for reduced inflammation include those with type 2 diabetes, underweight individuals, and athletes, but evidence is weaker and mostly from reviews.
Notable caveats: Across all outcomes, the evidence is overwhelmingly positive, raising significant concern for publication bias (null results less likely to be published). Many studies are narrative reviews rather than primary human trials, and statistical significance is often lacking (e.g., only 1 of 10 studies on allergic rhinitis and 1 of 9 on inflammation reported significant findings). Doses, durations, and specific populations are rarely reported, making practical recommendations impossible from the data alone.
Frequently asked
What is Lactobacillus acidophilus L-92 good for according to research?
Research shows the strongest evidence for reducing atopic dermatitis severity and improving symptoms, with 6 out of 6 studies reporting moderate beneficial effects in children and adults with atopic dermatitis. There is also moderate evidence for improving immune function, though this comes from 12 studies with small effect sizes and significant publication bias concerns.What dose of Lactobacillus acidophilus L-92 is typically used in studies?
Only one outcome (improved atopic dermatitis severity) reported a specific dose: 20 mg L-92 per day in one randomized controlled trial. Across most other outcomes, doses were not consistently reported, so no typical effective dose can be identified from the available research.Who benefits most from Lactobacillus acidophilus L-92?
The most robust evidence supports benefits for children and adults with clinically diagnosed atopic dermatitis, particularly in Japanese populations. Younger children (aged 1 month to 10 years) also show benefits for atopic dermatitis severity. Evidence for other populations like those with allergic rhinitis or type 2 diabetes is weaker and based mostly on reviews.Are there caveats or limitations in the research on Lactobacillus acidophilus L-92?
Yes, the evidence across all 12 outcomes is subject to publication bias—null results are less likely to be published. Many studies are narrative reviews rather than primary human trials, and statistical significance is often lacking. For example, only 1 of 10 studies on allergic rhinitis and 1 of 9 studies on inflammation reported statistically significant findings. Doses, durations, and populations are frequently unreported.Does Lactobacillus acidophilus L-92 help with allergic rhinitis?
Research suggests possible benefits—10 of 10 studies reported moderate beneficial effects on reducing allergic rhinitis symptoms. However, the evidence is weak (low evidence strength) because only 1 of those studies found statistically significant results, and all 10 studies were reviews rather than primary clinical trials.Does Lactobacillus acidophilus L-92 improve immune function?
There is consistent but weak evidence—12 of 12 studies reported beneficial effects on immune function, but the effect size is predominantly small. The most robust evidence comes from one systematic review (n=1,502) showing small benefits and one small RCT (n=50) that reached statistical significance. However, the evidence is dominated by narrative reviews and subject to publication bias.
- Moderate evidenceReduced Atopic Dermatitis Severity
- Moderate evidenceImproved Atopic Dermatitis Severity
- Moderate evidenceImproved Atopic Dermatitis Symptoms
- Low evidenceImproved Immune Function
- Low evidenceReduced Allergic Symptoms
- Low evidenceReduced Severity of Allergic Rhinitis Symptoms
- Low evidenceReduced Inflammation
- Low evidenceImproved Gut Health
- Low evidenceImproved Immune Modulation
- Low evidenceIncreased Antioxidant Activity